Skip to main content

Table 3 The five elements of the outcomes

From: Comparison of Buyang Huanwu granules and Naoxintong capsules in the treatment of stable angina pectoris: rationale and design of a randomized, blinded, multicentre clinical trial

Domain

Specific measurement

Specific metric

Method of aggregation

Time-points

Primary outcome

 Stable angina symptom score

Symptom score standard classification [22]

Difference between two groups

Proportion

Baseline, 28 days after treatment

Secondary outcomes

 ECG parameters

Classification of 12-lead ECG improvement [23]

Difference between two groups

Proportion

Baseline, 28 days after treatment

 SAQ scores

SAQ [24]

Difference in the change between groups

Mean/ median

Baseline, 28 days after treatment

 Nitroglycerin consumption

Count

Compare the difference between groups

Median

Baseline, 28 days after treatment

Safety outcomes

 Vital signs

Heart rate, respiration, body temperature, blood pressure

Compare the difference between groups

Mean/ median

Run-in period, baseline, 28 days after treatment

 Clinical laboratory tests

Routine blood test, routine urinalysis, serum biochemistry, blood coagulation index, and fasting blood glucose

Compare the difference between groups

Mean/ median

Baseline, 28 days after treatment

 AEs, SAEs

Common Terminology Criteria for AEs version 4.03.

Compare the difference between groups

Proportion

Baseline, 28 days after treatment

  1. ECG electrocardiogram, SAQ Seattle Angina Questionnaire